Efficacies of sorafenib plus interferon in advanced renal cell carcinoma: a report of 57 cases

摘要

Objective To explore the efficacies and adverse events of sorafenib in the treatment of advanced metastatic renal cell carcinoma.Methods A total of 57 patients with advanced kidney cancer were recruited from our hospital from April 2007 to October 2011.They were divided into sorafenib group (A,n=24) and sorafenib+